>6monthsat-80°C.

1.Leong,H.etal.(2005)Mol.Endocrinol.19,2930-2942.
2.Zhaoetal.,(2005)Mol.Cell.Biol.25,8456-8464.

ApplicationReference(s):
1. AnazumamideCanaloguewithoutthezinc-bindingfunctionality(2017)
2. Impactofbindingmechanismonselectiveinhibitionofhistonedeacetylaseisoforms(2017)
3. PromiscuousactionsofsmallmoleculeinhibitorsoftheproteinkinaseD-classIIaHDACaxisinstriatedmuscle(2015)
4.Design,synthesis,3Dpharmacophore,QSAR,anddockingstudiesofcarboxylicacidderivativesasHistoneDeacetylaseinhibitorsandcytotoxicagents(2014)
5.InVivoImagingofHistoneDeacetylases(HDACs)intheCentralNervousSystemandMajorPeripheralOrgans(2014)
6.ThermodynamicsofligandbindingtohistonedeacetylaselikeamidohydrolasefromBordetella/Alcaligenes(2014)
7.AselectiveHDAC1/2inhibitormodulateschromatinandgeneexpressioninbrainandaltersmousebehaviorintwomood-relatedtests(2013)
8.FDG-PETimagingrevealslocalbrainglucoseutilizationisalteredbyclassIhistonedeacetylaseinhibitors(2013)
9.HighlyligandefficientandselectiveN-2-(Thioethyl)picolinamidehistonedeacetylaseinhibitorsinspiredbythenaturalproductpsammaplinA(2013)
10.ImagingepigeneticregulationbyhistonedeacetylasesinthebrainusingPET/MRIwith¹⁸F-FAHA(2013)
11.SantacruzamateA,apotentandselectivehistonedeacetylaseinhibitorfromthePanamanianmarinecyanobacteriumcf.Symplocasp(2013)
12.SelectiveclassIIahistonedeacetylaseinhibitionviaanonchelatingzinc-bindinggroup(2013)
13.TasquinimodIsanAllostericModulatorofHDAC4survivalsignalingwithinthecompromisedcancermicroenvironment(2013)